Price
Target price
€7.25
€7.25
0.250%
0.018
0.250%
€12.95
26.09.24 / Tradegate
WKN: A2JQ1X / Symbol: BHC / Name: Bausch Health Companies / Stock / Pharmaceuticals / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bausch Health Companies Inc. Stock
Bausch Health Companies Inc. gained 0.250% compared to yesterday.
Bausch Health Companies Inc. is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
With a target price of 12 € there is a hugely positive potential of 65.49% for Bausch Health Companies Inc. compared to the current price of 7.25 €.
Our community identified positive and negative aspects for Bausch Health Companies Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bausch Health Companies Inc. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bausch Health Companies Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bausch Health Companies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc. | 0.250% | -1.118% | 35.431% | -6.811% | -0.151% | -70.452% | -63.449% |
| Opko Health Inc. | 2.180% | 2.056% | -8.535% | -7.419% | -5.253% | -56.644% | -29.424% |
| Catalent Inc. | -0.370% | 0.391% | 1.392% | 24.671% | 30.874% | -53.915% | 24.397% |
| Amicus Therapeutics Inc. | -1.550% | -2.062% | -7.767% | -18.103% | -28.030% | 2.703% | 27.946% |
Comments
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Jefferies Financial Group Inc. from $13.00 to $9.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BHC provided by MarketBeat
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for BHC provided by MarketBeat